IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Advanced Biomed Inc (ADVB)

CUSIP: 00752P203 | NYSE | 4 institutional holders

Quarters

Q3 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/APau Hung To00.0%Fell below 5%Jul 27, 2026No 13F filer matched
13GLEE Chen YI
with Advance on Ventures Ltd
123,8407.5%New 5%+ stake

Institutional Holders — Q3 2026

Geode Capital Management, LLC20,170
0.0% of portfolio›$125.7K
UBS Group AG4,474
0.0% of portfolio›$27.9K
Valley National Advisers Inc1,000
0.0% of portfolio›$6.2K
Caitong International Asset Management Co., Ltd9
0.0% of portfolio›$56
StyleTurnoverLocationFiled
Geode Capital Management, LLC
20,170$125.7K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
4,474$27.9K0.0%CoreMediumZurich, Switzerland2026-11-10
Valley National Advisers Inc
1,000$6.2K0.0%ETFLowBethlehem, PA2026-10-23
Caitong International Asset Management Co., Ltd
9$560.0%GrowthVery HighHong Kong, South Korea2026-10-29
Mar 6, 2025
No 13F filer matched
13G/APau Hung To0
0.0% of class · Jul 27, 2026Fell below 5%
No 13F filer matched
13GLEE Chen YI123,840
7.5% of class · Mar 6, 2025New 5%+ stake
with Advance on Ventures Ltd
No 13F filer matched